Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Increased epidermal turnover refers to a process in which cells in the epidermis proliferate, migrate, differentiate, and are shed at an accelerated rate. Normally, keratinocytes originate from stem cells in the basal layer and travel through the epidermal layers, becoming corneocytes that are eventually sloughed off at the skin surface[2][3][4][8]. The whole process takes 28–40 days in healthy adults but can be accelerated in certain conditions, notably psoriasis, where cell proliferation is greatly increased and cells are shed prematurely before full keratinization[1][5][6][7][8]. Epidermal turnover is regulated by multiple signaling pathways including EGF, FGF, Wnt, Notch, Hedgehog, BMP/TGFβ, and integrins[1]. Increasing turnover can be therapeutically beneficial for some skin conditions, but excessive or uncontrolled acceleration can impair barrier function and cause or worsen dermatitis, inflammation, or infection[1][4][8].
Induction of keratinocyte proliferation Acceleration of differentiation and upward migration Enhanced desquamation (shedding) of corneocytes Modulation of cellular signals such as EGF, FGF, Wnt, Notch, BMP/TGFβ, integrins
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Increased epidermal turnover.